• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cell Mol Med . Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior

tetano

Editor, Senior Moderator
J Cell Mol Med


. 2022 Jan 18.
doi: 10.1111/jcmm.17186. Online ahead of print.
Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19


Mihaela Chivu-Economescu[SUP] 1 [/SUP], Coralia Bleotu[SUP] 1 [/SUP], Camelia Grancea[SUP] 1 [/SUP], Daniela Chiriac[SUP] 1 [/SUP], Anca Botezatu[SUP] 1 [/SUP], Iulia V Iancu[SUP] 1 [/SUP], Ioana Pitica[SUP] 1 [/SUP], Laura G Necula[SUP] 1 [/SUP], Ana Neagu[SUP] 1 [/SUP], Lilia Matei[SUP] 1 [/SUP], Denisa Dragu[SUP] 1 [/SUP], Camelia Sultana[SUP] 1 2 [/SUP], Elena L Radu[SUP] 1 3 [/SUP], Alina Nastasie[SUP] 1 [/SUP], Oana Voicu[SUP] 1 [/SUP], Marius Ataman[SUP] 1 [/SUP], Saviana Nedeianu[SUP] 1 [/SUP], Cristina Mambet[SUP] 1 2 [/SUP], Carmen C Diaconu[SUP] 1 [/SUP], Simona Maria Ruta[SUP] 1 2 [/SUP]



Affiliations

Abstract

SARS-CoV-2 vaccines are highly efficient against severe forms of the disease, hospitalization and death. Nevertheless, insufficient protection against several circulating viral variants might suggest waning immunity and the need for an additional vaccine dose. We conducted a longitudinal study on the kinetics and persistence of immune responses in healthcare workers vaccinated with two doses of BNT162b2 mRNA vaccine with or without prior SARS-CoV-2 infection. No new infections were diagnosed during follow-up. At 6 months, post-vaccination or post-infection, despite a downward trend in the level of anti-S IgG antibodies, the neutralizing activity does not decrease significantly, remaining higher than 75% (85.14% for subjects with natural infection, 88.82% for vaccinated after prior infection and 78.37% for vaccinated only). In a live-virus neutralization assay, the highest neutralization titres were present at baseline and at 6 months follow-up in persons vaccinated after prior infection. Anti-S IgA levels showed a significant descending trend in vaccinated subjects (p < 0.05) after 14 weeks. Cellular immune responses are present even in vaccinated participants with declining antibody levels (index ratio 1.1-3) or low neutralizing activity (30%-40%) at 6 months, although with lower T-cell stimulation index (p = 0.046) and IFN-γ secretion (p = 0.0007) compared to those with preserved humoral responses.

Keywords: IFN-γ; SARS-CoV-2 infection; antibody levels; immune response post-infection; immune response post-vaccination; mRNA vaccine; neutralizing antibodies; spike-specific CD4+ T cell; spike-specific CD8+ T cell.
 
Back
Top Bottom